Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?

SIMPLE SUMMARY: There is growing interest in identifying the effects of antidiabetic agents on cancer risk, progression, and anti-cancer treatment due to the long-term use of these medications and the inherently increased risk of malignancies in diabetic patients. Tumor development and progression a...

Descripción completa

Detalles Bibliográficos
Autores principales: Busek, Petr, Duke-Cohan, Jonathan S., Sedo, Aleksi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103952/
https://www.ncbi.nlm.nih.gov/pubmed/35565202
http://dx.doi.org/10.3390/cancers14092072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103952/
https://www.ncbi.nlm.nih.gov/pubmed/35565202
http://dx.doi.org/10.3390/cancers14092072

Ejemplares similares